Back to Agenda
Session 1 - Health Canada Update
Session Chair(s)
Rita Cassola, RPH
Executive Director PV
Certus PV Services Inc, Canada
Session 1 - Health Canada Update
Speaker(s)
Draft Guidance Document for Preparing a Post-Market Benefit-Risk Assessment
Matthew P LeBrun, MS
Health Canada, Canada
Scientific Evaluator
Inspections
Katarina Susnjar
Health Canada, Canada
Compliance and Enforcement Specialist, Clinical Trial Compliance Program (CTCP)
Risk Management Plan Draft Guidance
Rania Mouchantaf, PHD
Health Canada, Canada
A/Executive Director, Marketed Pharmaceuticals Bureau, MHPD
Have an account?